Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting

Go back to Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting
(NASDAQ: EVAX) Delayed: 3.71 --0 (-0%)
Previous Close $3.71    52 Week High $ 
Open $3.73    52 Week Low $ 
Day High $3.75    P/E N/A 
Day Low $3.55    EPS $ 
Volume 107,790